IRF8 and pulmonary arterial hypertension: A study by Bai et al. [43] suggested that IRF1 and IRF8 might be potential regulators of the SPHK1 (the sphingosine pathway promotes vascular remodeling and induces PAH) overexpression gene set signature in human PASMCs.